DBTECH

Dear Reader, As per your request, you have been removed from our mailing list for Markets Morning Get all the updates from the world of business straight to your inbox Getting bigger and stronger. 4 million+ subscribers MANAGE ALL NEWSLETTERS » Daily Newsletter

VIEW IN BROWSER | SUBSCRIBE THU, MAY 30, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good afternoon! This is Annika, and I'll be on the ground at the American Society of Clinical Oncology annual meeting in Chicago in the coming days.    So will thousands of cancer researchers and clinicians, who expect to see encouraging new science and data that could advance cancer treatments, health equity and patient care.    More than 5,000 research abstracts will be presented or published at ASCO, which starts on Friday and lasts until Tuesday. There will be data on existing drugs from pharmaceutical companies, experimental treatments in early to mid-stage testing from biotech companies and even AI tools.    I'll be focusing on some of the larger names in the industry. Here